Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers

The use of generic drugs has been increasing. However, studies of the safety of generic cisplatin (CDDP) for the treatment of head and neck cancer (HNC) have not been reported. This study investigated the treatment completion rates and incidence of CDDP-related adverse events in patients with advanc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Jpn Clin Med
Hlavní autoři: Shimada, Rie, Tsukahara, Kiyoaki, Takase, Soichiro, Okamoto, Isaku, Sato, Hiroki, Katsube, Yasuaki, Maruyama, Ryo, Shimizu, Akira
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802811/
https://ncbi.nlm.nih.gov/pubmed/29434483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179670717749231
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky